Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Events

Latest News

Global Injectable Drug Delivery Market Size, Trends and Forecast to 2024

electronic medical records software

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration  (Skin, Circulatory, Organs, Central Nervous System), End User  (Hospitals & Clinics, Home Care Settings, Research Laboratories,  Pharma & Biotech Companies), Geography (North America,  Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024

The Global injectable drug delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market

Segmentation:

By Type (Devices {Conventional Injection, Self-Injection},  Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma& Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa)

Drivers:

Some of the major factors driving the market for injectable drug delivery market, such as increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. Increasing prevalence of chronic diseases, rising demand for self-injection devices, growth of the biologics, and technological advancements are the major factors driving the growth of the injectable drug delivery market.GROWING GERIATRIC POPULATION

RISING CASES OF CHRONIC DISEASES

In recent years, the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand forself-injection devices and cost of healthcare.

RISING DEMAND OF SELF-INJECTION DEVICES

 

Self-injection devices are a combination of automatic injection systems with audio-visual guides for surgeries; this includes safety syringes and hidden needles, among others. It has also emerged as one of the fastest growing areas for unit dose medication in order to minimize drug waste and increase product lifespan.

GROWTH OF BIOLOGICS MARKET

The biologics market is considered to be the fastest-growing sector of the pharmaceutical industry. Biologics are large molecules that require to be administered by injections given their size and profile. Biologics are medicines made from living cells through highly complex manufacturing processes used to prevent, treat, diagnose, or cure a variety of serious and chronic illnesses including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases.

TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET

The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of administration of parenteral therapeutics.

Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/

Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa.

The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

Some of the major players operating in this market are

  • Baxter International, Inc.
  • Becton Dickinson and Company
  • Gerresheimer AG
  • Pfizer, Inc.
  • Schott AG
  • Alkermes Plc.
  • Eli Lilly and Company
  • Sandoz
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Bespak
  • Antares Pharma
  • Elcam Medical
  • Haselmeier
  • Mylan N.V.
  • Novo Nordisk
  • Owen Mumford Ltd
  • Sanofi
  • West Pharmaceutical Services, Inc
  • Ypsomed Holding AG.

 

Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market

Table Of Content:

  1. INTRODUCTION

1.1. OVERVIEW OF THE INJECTABLE DRUG DELIVERY MARKET

1.2. MARKET SEGMENTATION & COVERAGE

1.2.1. CURRENCY AND PRICING

1.2.2. LIMITATION

1.2.3. STAKEHOLDERS

  1. RESEARCH METHODOLOGY

2.1. KEY TAKEAWAYS

2.2. ARRIVING AT THE INJECTABLE DRUG DELIVERY MARKET SIZE

2.2.1. MARKET CRACKDOWN APPROACH

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3. DATA TRIANGULATION

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

2.2.6. PORTER’S FIVE FORCES MATRIX

2.3. GLOBAL INJECTABLE DRUG DELIVERY MARKET: RESEARCH SNAPSHOT

2.4. ASSUMPTIONS

  1. MARKET LANDSCAPE SUMMARY
  2. PREMIUM INSIGHTS

4.1. OVERVIEW

4.2. INJECTABLE DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS

4.3. MARKET OVERVIEW

4.3.1. DRIVERS

4.3.1.1. RISING PREVALENCE OF CHRONIC DISEASES

4.3.1.2. INCRESING DEMAND OF SELF INJECTION DEVICES

4.3.1.3. GROWTH OF BILOGICS AND BIOSIMILARS MARKET

4.3.1.4. TECHNOLOGICAL ADVANCEMENTS IN DRUG DELIVERY MARKET

4.3.2. RESTRAINTS

4.3.3. OPPORTUNITIES

4.3.3.1. INCRESING DEMAND FOR GENERIC INJECTABLES

4.3.4. THREATS

4.3.4.1. PRODUCT RECALLS

4.3.4.2. REGULATORY HURDLES

4.3.4.3. STABILITY OF PRODUCTS

4.3.4.4. STERILITY OF INJECTIONS

4.3.4.5. GROWING DEMAND OF OTHER DRUG DELIVERY TECHNOLOGIES

4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

  1. INJECTABLE DRUG DELIVERY MARKET, BY TYPE

5.1. OVERVIEW

5.2. INJECTABLE DRUG DELIVERY DEVICES

5.3. INJECTABLE DRUG DELIVERY FORMULATIONS

  1. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

6.2. CONVENTIONAL INJECTION DEVICES

6.2.1. BY MATERIAL

6.2.1.1. GLASS

6.2.1.2. PLASTIC

6.2.2. BY PRODUCT

6.2.2.1. EMPTY SYRINGES

6.2.2.2. PREFILLED SYRINGES

6.2.3. BY USABLITY

6.2.3.1. REUSABLE SYRINGES

6.2.3.2. DISPOSABLE SYRINGES

6.3. SELF INJECTION DEVICES

6.3.1. NEEDLE FREE INJECTORS

6.3.1.1. BY PRODUCT

6.3.1.1.1. EMPTY NEEDLE FREE INJECTORS

6.3.1.1.2. PREFILLED NEEDLE FREE INJECTORS

6.3.1.2. BY TECHNOLOGY

6.3.1.2.1. JET BASED NEEDLE FREE INJECTORS

6.3.1.2.2. SPRING BASED NEEDLE FREE INJECTORS

6.3.1.2.3. LASER POWERED NEEDLE FREE INJECTORS

6.3.1.2.4. VIBRATION BASED NEEDLE FREE INJECTORS

6.3.1.3. BY USABILITY

6.3.1.3.1. REUSABLE NEEDLE FREE INJECTORS

6.3.1.3.2. DISPOSABLE NEEDLE FREE INJECTORS

6.3.2. AUTOINJECTORS

6.3.2.1. BY PRODUCT

6.3.2.1.1. EMPTY AUTOINJECTORS

6.3.2.1.2. PREFILLED AUTOINJECTORS

6.3.2.2. BY TECHNOLOGY

6.3.2.2.1. AUTOMATED AUTOINJECTORS

6.3.2.2.2. MANUAL AUTOINJECTORS

6.3.2.3. BY DESIGN

6.3.2.3.1. STANDARDIZED AUTOINJECTORS

6.3.2.3.2. CUSTOMIZED AUTOINJECTORS

6.3.2.4. BY USABILITY

6.3.2.4.1. REUSABLE AUTOINJECTORS

6.3.2.4.2. DISPOSABLE AUTOINJECTORS

6.3.3. PEN INJECTORS

6.3.3.1. BY PRODUCT

6.3.3.1.1. SINGLE CHAMBERED PEN INJECTORS

6.3.3.1.2. DUAL CHAMBERED PEN INJECTORS

6.3.3.2. BY DESIGN

6.3.3.2.1. STANDARDIZED PEN INJECTORS

6.3.3.2.2. CUSTOMIZED PEN INJECTORS

6.3.3.3. BY USABILITY

6.3.2.3.1. REUSABLE PEN INJECTORS

6.3.2.3.2. DISPOSABLE PEN INJECTORS

6.3.4. WEARABLE INJECTORS

6.3.5. OTHER INJECTABLE DEVICES

  1. INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE

7.1. OVERVIEW

7.2. CONVENTIONAL DRUG DELIVERY FORMULATIONS

7.2.1. SOLUTIONS

7.2.2. RECONSTITUTED/LYOPHILIZED FORMULATIONS

7.2.3. SUSPENSIONS

7.2.4. EMULSIONS

7.3. NOVEL DRUG DELIVERY FORMULATIONS

7.3.1. COLLOIDAL DISPERSIONS

7.3.1.1. LIPOSOMES

7.3.1.2. NIOSOMES

7.3.1.3. POLYMERIC MIXED MICELLES

7.3.1.4. NANOPARICLES

7.3.1.4.1. NANOSUSPENSIONS

7.3.1.4.2. NANOEMULSIONS/MICROEMULSIONS

7.3.1.4.3. SOLID LIPID NANOPARTICLES

7.3.2. MICROPARTICLES

7.3.2.1. MICROSPHERES

7.3.2.2. MICROCAPSULES

7.3.3. LONG ACTING INJECTION FORMULATIONS

  1. INJECTABLE DRUG DELIVERY MARKET, BY APPLICATIONS

8.1. OVERVIEW

8.2. AUTOIMMUNE DISEASES

8.2.1. RHEUMATOID ARTHRITIS

8.2.2. MULTIPLE SCLEROSIS

8.2.3. CHRON’S DISEASE

8.2.4. PSORIASIS

8.2.5. OTHER AUTOIMMUNE DISEASES

8.3. HORMONAL DISORDERS

8.3.1. DIABETES

8.3.2. ANEMIA

8.3.3. REPRODUCTIVE HEALTH DISEASE

8.3.4. ANTITHROMBOTIC/THROMBOLYTIC THERAPY

8.3.5. OSTEOPOROSIS

8.3.6. GROWTH HORMONE DEFICIENCY (GHD)

8.4. ORPHAN DISEASES

8.5. ONCOLOGY

8.6. OTHERS

8.6.1. PAIN MANAGEMENT

8.6.2. ALERGY TREATMENT

8.6.3. AESTHETIC TREATMENTS

8.6.4. HEPATITIS C

8.6.5. HEMOPHILIA

  1. INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN

9.1. OVERVIEW

9.2. CURATIVE CARE

9.3. IMMUNIZATIONS

9.4. OTHER USAGE PATTERNS (BLOOD TRANSFUSION, BLOOD PRODUCTS, AND CONTRACEPTIVES)

  1. INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION

10.1. OVERVIEW

10.2. SKIN

10.3. CIRCULATORY/MUSKOSKELETAL

10.4. ORGANS

10.5. CENTRAL NERVOUS SYSTEM

  1. INJECTABLE DRUG DELIVERY MARKET, BY END USER

11.1. OVERVIEW

11.2. HOSPITALS AND CLINICS

11.3. HOME HEALTHCARE SETTINGS

11.4. RESEARCH LABORATORIES

11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES

11.6. OTHER END USERS

  1. INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY

12.1. COUNTRYWISE  INJECTABLE DRUG DELIVERY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

12.1.1. NORTH AMERICA

12.1.1.1. U.S.

12.1.1.2. CANADA

12.1.1.3. MEXICO

12.1.2. EUROPE

12.1.2.1. GERMANY

12.1.2.2. FRANCE

12.1.2.3. U.K.

12.1.2.4. ITALY

12.1.2.5. SPAIN

12.1.2.6. RUSSIA

12.1.2.7. TURKEY

12.1.2.8. BELGIUM

12.1.2.9. NETHERLANDS

12.1.2.7. SWITZERLAND

12.1.2.8. REST OF EUROPE

12.1.3. ASIA-PACIFIC (APAC)

12.1.3.1. JAPAN

12.1.3.2. CHINA

12.1.3.3. SOUTH KOREA

12.1.3.4. INDIA

12.1.3.5. AUSTRALIA

12.1.3.6. SINGAPORE

12.1.3.7. THAILAND

12.1.3.8. MALAYSIA

12.1.3.9. INDONESIA

12.1.3.10. PHILIPPINES

12.1.3.11. REST OF APAC

12.1.4. LATIN AMERICA

12.1.4.1. BRAZIL

12.1.4.2. REST OF LATIN AMERICA

12.1.5. MIDDLE EAST AND AFRICA

12.1.5.1. SOUTH AFRICA

12.1.5.2. REST OF MIDDLE EAST AND AFRICA

12.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. INJECTABLE DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE

13.1. GLOBAL INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

13.2. U.S. INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

13.3. EUROPE INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

13.4. APAC INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

13.5. SOUTH AMERICA INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

13.6. MIDDLE EAST AND AFRICA  INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

13.7. MERGERS & ACQUISITIONS

13.8. NEW PRODUCT DEVELOPMENT & APPROVALS

13.9. EXPANSIONS

13.10. REGULATORY CHANGES

13.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

  1. INJECTABLE DRUG DELIVERY MARKET, COMPANY PROFILES

14.1. BAXTER INTERNATIONAL, INC.

14.1.1. OVERVIEW

14.1.2. SWOT ANALYSIS

14.1.3. PRODUCT PORTFOLIO

14.1.4. REVENUE ANALYSIS

14.1.5. ANALYSTS VIEW

14.2. BECTON, DICKINSON AND COMPANY

14.2.1. OVERVIEW

14.2.2. SWOT ANALYSIS

14.2.3. PRODUCT PORTFOLIO

14.2.4. REVENUE ANALYSIS

14.2.5. ANALYSTS VIEW

14.3. GERRESHEIMER, AG

14.3.1. OVERVIEW

14.3.2. SWOT ANALYSIS

14.3.3. PRODUCT PORTFOLIO

14.3.4. REVENUE ANALYSIS

14.3.5. ANALYST VIEW

14.4. PFIZER, INC.

14.4.1. OVERVIEW

14.4.2. SWOT ANALYSIS

14.4.3. PRODUCT PORTFOLIO

14.4.4. REVENUE ANALYSIS

14.4.5. ANALYSTS VIEW

14.5. SCHOTT AG

14.5.1. OVERVIEW

14.5.2. SWOT ANALYSIS

14.5.3. PRODUCT PORTFOLIO

14.5.4. REVENUE ANALYSIS

14.5.5. ANALYSTS VIEW

14.6. ALKERMES PLC

14.6.1. OVERVIEW

14.6.2. SWOT ANALYSIS

14.6.3. PRODUCT PORTFOLIO

14.6.4. REVENUE ANALYSIS

14.6.5. ANALYSTS VIEW

14.7. ELI LILLY AND COMPANY

14.7.1. OVERVIEW

14.7.2. SWOT ANALYSIS

14.7.3. PRODUCT PORTFOLIO

14.7.4. REVENUE ANALYSIS

14.7.5. ANALYSTS VIEW

14.8. SANDOZ

14.8.1. OVERVIEW

14.8.2. SWOT ANALYSIS

14.8.3. PRODUCT PORTFOLIO

14.8.4. REVENUE ANALYSIS

14.8.5. ANALYSTS VIEW

14.9. TERUMO CORPORATION

14.9.1. OVERVIEW

14.9.2. SWOT ANALYSIS

14.9.3. PRODUCT PORTFOLIO

14.9.4. REVENUE ANALYSIS

14.9.5. ANALYSTS VIEW

14.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.

14.10.1. OVERVIEW

14.10.2. SWOT ANALYSIS

14.10.3. PRODUCT PORTFOLIO

14.10.4. REVENUE ANALYSIS

14.10.5. ANALYSTS VIEW

  1. APPENDIX

15.1. RELATED REPORTS

15.2. CUSTOMIZABLE OPTIONS

15.3. SOURCE SHEET

15.4. BIBLIOGRAPHY

  1. ABOUT DATA BRIDGE MARKET RESEARCH

 

 

Related Report

Global Hemostats Market- Trends and Forecast to 2024

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/medical-devices/general-surgery-medical-devices/global-hemostats-market-trends-forecast-2024/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog http://databridgemarketresearch.com/blog/

HIMSS Special Part 1: HIT Visionary Zach Fox
Check out industry insight from HIT visionary and DrFirst Executive VP and GM, Zach Fox. Visit DrFirst at HIMSS Booth 6232.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.
×
×
WordPress Popup
HIMSS Special Part 1: HIT Visionary David Lareau
Check out industry insight from HIT visionary and Medicomp CEO, David Lareau. Visit Medicomp at HIMSS Booth 3421
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.
×
×
WordPress Popup
casipoldiyarbetetabetetabetw88w88w88betfokusbetfokuslordbahisparobetparobetbuzbahisbullbahiscasino sérieuxcasino sérieuxcasino sérieuxcasino sérieuxcasino en ligne populairemeilleur site de jeux casino en lignemeilleur site de jeux casino en lignecasino en ligne en francecasino en ligne en francecasino en ligne de confiancebetbinanstwinplayistanbulbahisistanbulbahisistanbulbahisparis sportifs hors arjelonwin üyeliksahabet üyelikrestbet girişpulibetsüperbetinbtcbahiscanlı casino sitelerionline casino1xbet mobilligobet mobilcapitolbetmostbet üyelikbizbet üyelikgobahis girişmatbet girişikimisli girişbordobet girişbetcio girişalfabahisalfabahisbetgoowinxbetwinxbetwinxbetwinxbetbetkanyontaksimbetrexabetrexabetrexabetenobahisbookmaker hors arjelparis sportifs en Italieparier sur les cornersparier sur le nombre de tirsmystake chickenparis hippiques en ligneplinko francecasino diceBetzinoVasyCbetCasino Lucky8betkanyonbetkanyontaksimbettaksimbettaksimbettaksimbetbetistbetistbetistenobahisenobahisenobahisbetkolikbetkoliksmartbahissmartbahissmartbahistrendbettrendbetgamabetgamabetgamabetgamabetaspercasinoaspercasinoaspercasinonisanbetnisanbetnewbahismelbetonbahisbetonredbetonredromabettipobettipobetefes casinobetandreasfixbetbetbababetbababuzbahisbuzbahisbullbahisbullbahisbetsofbetsofall right casinokombinebetbetbinansbetbinansbetbinansmaksatbahisbetbabaorisbetorisbetbizimbahissiyahbethayalbahishayalbahishilbetsantosbettingsantosbettingsantosbettingsantosbettingnerobetnerobetswordbetswordbetswordbetinbahislevabetlevabetlevabetcasiveracasiveracasiverakordonbetkareasbetprincessbetkikbetkikbetkikbetbetmarketbetmarketbetmarketyapbahsinibetingoasyabahishipercasinocasinoperbahisnowsüpertotobetalibahisfaulbetfaulbetrelaxbahisbetingoasyabahiscasinopercasinoperbahisnowbahisnowpiyasabetpiyasabetyonjabetcasinoslotbetibombetibomredwin